Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

Clinical trial NCT05138705 · COMPLETED

Trial details

NCT number: NCT05138705
Sponsor: Shanghai Institute Of Biological Products
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2021-12-14
Primary completion: 2022-02-28
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.